home.social

#aha22 — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #aha22, aggregated by home.social.

fetched live
  1. EMPA-KIDNEY: Among a wide range of patients w/ CKD who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from CV causes (vs. placebo) ca. 2022
    #KidneyWk #AHA22 #Nephpearls

    👉🏼 nejm.org/doi/full/10.1056/NEJM

  2. @mike_johansen @hswapnil I wonder if, with all of the #LBCT publications in the past week from #KidneyWk and #AHA22, we can take overflow here. I'm usually not available during the twitter timeslot but would love to participate in one on one of the new resistant #hypertension meds 😎 🤓